May 15 |
NeuroMetrix GAAP EPS of -$1.67
|
May 15 |
NeuroMetrix Reports Q1 2024 Business Highlights
|
Apr 24 |
NeuroMetrix, Inc.'s (NASDAQ:NURO) CEO Might Not Expect Shareholders To Be So Generous This Year
|
Apr 19 |
NeuroMetrix names new independent director, terminates equity program; shares up
|
Apr 19 |
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
|
Mar 14 |
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
|
Mar 13 |
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
|
Mar 12 |
Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired
|
Mar 8 |
RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc.
|
Mar 4 |
Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc.
|